Molecular Mechanism of Insulin Resistance and Obesity


Obesity and insulin obstruction have been perceived as driving reasons for significant medical problems. We have tried to portray the atomic system of insulin obstruction, zeroing in on the capacity of adipocyte. We have researched a job of PPARγ on the pathogenesis of Type II diabetes. Heterozygous PPARγ-inadequate mice were shielded from the advancement of insulin opposition due to adipocyte hypertrophy under a high-fat eating routine. Also, a Pro12Ala polymorphism in the human PPARγ2 quality was related with diminished danger of Type II diabetes in Japanese. Taken along with these outcomes, PPARγ is end up being a frugal quality intervening Type II diabetes. Pharmacological inhibitors of PPARγ/RXR improve high-fat eating routine actuated insulin obstruction in creature models of Type II diabetes.



 


    Related Conference of Molecular Mechanism of Insulin Resistance and Obesity

    June 10-11, 2024

    24th Global Summit on Obesity

    Dubai, UAE
    June 27-28, 2024

    20th Euro Obesity and Endocrinology Congress

    London, UK
    August 29-30, 2024

    18th International Conference on Obesity Medicine

    Helsinki, Finland
    November 28-29, 2024

    25th Annual Meet on Obesity and Diet

    Bali, Indonesia

    Molecular Mechanism of Insulin Resistance and Obesity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in